Evidence map›Paper›PMID 38026160›Full record

ArticleiScience2023

Microwell-enhanced optical rapid antibiotic susceptibility testing of single bacteria.

Ireneusz Rosłon, Aleksandre Japaridze, Stef Rodenhuis, Lieke Hamoen, Murali Krishna Ghatkesar, Peter Steeneken, Cees Dekker, Farbod Alijani

Open access · goldAbstract read
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Synchronization of E. coli Bacteria Moving in Coupled Microwells.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ireneusz RosłonDelft University of Technology, Mekelweg 2, Delft 2628 CD, the Netherlands.
Aleksandre JaparidzeDelft University of Technology, Mekelweg 2, Delft 2628 CD, the Netherlands.
Stef RodenhuisDelft University of Technology, Mekelweg 2, Delft 2628 CD, the Netherlands.
Lieke HamoenDelft University of Technology, Mekelweg 2, Delft 2628 CD, the Netherlands.
Murali Krishna GhatkesarDelft University of Technology, Mekelweg 2, Delft 2628 CD, the Netherlands.
Peter SteenekenDelft University of Technology, Mekelweg 2, Delft 2628 CD, the Netherlands.
Cees DekkerDelft University of Technology, Mekelweg 2, Delft 2628 CD, the Netherlands.
Farbod AlijaniDelft University of Technology, Mekelweg 2, Delft 2628 CD, the Netherlands.
Delft University of Technology · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteria that are resistant to antibiotics present an increasing burden on healthcare. To address this emerging crisis, novel rapid antibiotic susceptibility testing (AST) methods are eagerly needed. Here, we present an optical AST technique that can determine the bacterial viability within 1 h down to a resolution of single bacteria. The method is based on measuring intensity fluctuations of a reflected laser focused on a bacterium in reflective microwells. Using numerical simulations, we show that both refraction and absorption of light by the bacterium contribute to the observed signal. By administering antibiotics that kill the bacteria, we show that the variance of the detected fluctuations vanishes within 1 h, indicating the potential of this technique for rapid sensing of bacterial antibiotic susceptibility. We envisage the use of this method for massively parallelizable AST tests and fast detection of drug-resistant pathogens.

Indexed as

Medical MicrobiologyMicrobiology

Identifiers

PMID38026160
PMCPMC10654606
OpenAlexW4387824733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.